Scholars Central

EditorialPublished 25 Jun 2012

Inflammation and Pancreatic Cancer: A Tale of Two Cytokines

Authors: Wei Li, Andrew M. Albrecht, Min Li

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pancreatic cancer is the most fatal of all gastrointestinal (GI) cancers, with only a 5.8% survival rate beyond five years after initial diagnosis. This cancer is characterized by a high mortality, rapid progression, and resistance to chemo and radiation therapy. Surgical resection is the only curative treatment for pancreatic cancer, but only less than 15% patients are eligible for surgery. The front-line treatment for metastatic pancreatic cancer has been adjuvant chemotherapy trials of gemcitabine and gemcitabine-based combinational therapy. However, over the past decade, no significant advances in efficacy of chemotherapeutic treatment have arisen, and the mean survival rate of those who have undergone such treatment has not improved.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cell Biology: Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCell Biology: Research & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Wei Li”
  • BylineArticles whose byline prints “Andrew M. Albrecht”
  • BylineArticles whose byline prints “Min Li”